三博脑科公告，公司作为有限合伙人与基金管理人、普通合伙人北京崇德英盛投资管理有限公司及其他 有限合伙人共同投资认购的北脑一期（北京）股权投资中心（有限合伙）基金份额，已完成私募基金备 案。基金名称为北脑一期（北京）股权投资中心（有限合伙），管理人为北京崇德英盛投资管理有限公 司，托管人为北京银行股份有限公司，备案日期为2026年1月9日，备案编码为SBKW58。 ...

证券代码：301293 证券简称：三博脑科 公告编号：2026-002 三博脑科医院管理集团股份有限公司 关于参与认购的投资基金完成私募基金备案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 为不断完善三博脑科医院管理集团股份有限公司（以下简称"公司"）产业链， 不断提升公司的临床诊疗水平，进一步增强公司的科技赋能，同时为充分利用资 本市场平台优势，借助专业投资机构的管理水平和投资经验，公司作为有限合伙 人与基金管理人、普通合伙人北京崇德英盛投资管理有限公司及其他有限合伙人 共同投资认购北脑一期（北京）股权投资中心（有限合伙）（以下简称"基金"） 份额，具体内容详见公司于 2025 年 8 月 27 日在巨潮资讯网披露的《关于与专业 投资机构共同投资认购基金份额的公告》（公告编号：2025-036）。 近日，北京崇德英盛投资管理有限公司已根据《证券投资基金法》和《私募 投资基金监督管理暂行办法》等法律法规的要求，在中国证券投资基金业协会完 成对基金的备案，并取得私募投资基金备案证明。 一、私募投资基金备案信息 基金名称：北脑一期（北京）股权投资中心（有 ...

Group 1 - The A-share market saw a strong performance in brain-computer interface concept stocks, with several companies approaching or hitting their daily limit up [1] - Notable gainers included Entropy Technology, which approached a 20% limit up, and Dao's Technology and Yingkang Life, both rising over 13% [1] - Other significant performers included Tom Cat, which increased by over 10%, and Yanshan Technology, which hit a 10% limit up [1] Group 2 - The table lists various companies with their respective stock codes, percentage increase, total market capitalization, and year-to-date performance [2] - Entropy Technology (301330) had a 19.40% increase, with a market cap of 11.7 billion and a year-to-date increase of 50.11% [2] - Dao's Technology (300409) rose by 13.91%, with a market cap of 25.9 billion and a year-to-date increase of 47.49% [2] - Yingkang Life (300143) increased by 13.01%, with a market cap of 10 billion and a year-to-date increase of 35.43% [2] - Other companies like Tom Cat (300459) and Yanshan Technology (002195) also showed significant gains, with year-to-date increases of 29.63% and 60.65% respectively [2]

Core Viewpoint - The A-share market has seen a strong performance in brain-computer interface concept stocks, with several companies approaching or hitting their daily price limits [1] Group 1: Stock Performance - Entropy Technology (熵基科技) approached a 20% daily limit increase, with a rise of 19.40% and a market capitalization of 11.7 billion [2] - Dao's Technology (道氏技术) increased by 13.91%, reaching a market cap of 25.9 billion [2] - Yingkang Life (盈康生命) rose by 13.01%, with a market cap of 10 billion [2] - Tom Cat (汤姆猫) saw a 10.19% increase, with a market cap of 20.9 billion [2] - Rock Mountain Technology (岩山科技) hit a 10% daily limit increase, with a market cap of 64.6 billion [2] - Three Seven Entertainment (三七互娱) approached a 10% daily limit increase, with a rise of 9.97% and a market cap of 66.4 billion [2] - Other notable performers include Aipeng Medical (爱朋医疗) at 9.99%, Lens Technology (蓝思科技) at 9.80%, and Nanjing Panda (南京熊猫) at 9.33% [2] Group 2: Year-to-Date Performance - Entropy Technology has a year-to-date increase of 50.11% [2] - Dao's Technology has risen 47.49% year-to-date [2] - Yingkang Life has a year-to-date increase of 35.43% [2] - Tom Cat has increased by 29.63% year-to-date [2] - Rock Mountain Technology has a significant year-to-date increase of 60.65% [2] - Aipeng Medical has a year-to-date increase of 54.31% [2] - Nanjing Panda has a remarkable year-to-date increase of 63.01% [2] - Other companies like Innovation Medical (创新医疗) and Keda Xunfei (科大讯飞) have year-to-date increases of 74.01% and 19.29%, respectively [2]

Market Overview - The Shanghai Composite Index increased by 3.82% this week, with 100 stocks experiencing a turnover rate exceeding 100% [1] - A total of 100 stocks had a turnover rate above 100%, while 366 stocks had a turnover rate between 50% and 100%, and 2793 stocks had a turnover rate between 10% and 50% [1] - The mechanical equipment sector had the highest number of stocks with a turnover rate over 100%, totaling 16 stocks, followed by the power equipment and electronics sectors with 11 and 10 stocks, respectively [1] High Turnover Stocks - Xin Guo Yi had the highest turnover rate at 270.52%, but its stock price fell by 8.44% during the week [2] - C Shan Lv followed with a turnover rate of 214.89% and a stock price decline of 1.67%, with a net inflow of 761.9 million yuan from major funds [2] - Yu Yin Co ranked third with a turnover rate of 210.60% and a slight price drop of 0.53%, experiencing a net outflow of 306 million yuan from major funds [2] Performance of High Turnover Stocks - Stocks with a turnover rate over 100% averaged a price increase of 16.80% this week, with 83 stocks rising and 17 stocks falling [2] - The top gainers included Shaoyang Hydraulic, Sanbo Brain Science, and Puni Testing, with increases of 84.91%, 56.15%, and 51.77%, respectively [2] - The largest declines were seen in Jin Hao Medical, Hongyuan Pharmaceutical, and Xin Guo Yi, with decreases of 17.74%, 11.60%, and 8.44%, respectively [2] Annual Performance Forecasts - Among the stocks with a turnover rate over 100%, 8 companies released annual performance forecasts, with 5 expecting profit increases and 1 expecting a profit [3] - Nanxing Co is projected to have the highest net profit growth, with a median expected profit of 105 million yuan, representing a year-on-year increase of 159.95% [3]

Core Viewpoint - The A-share market experienced a collective rise today, with significant gains across major indices and various sectors showing strong performance, particularly in AI applications, commercial aerospace, and small metals [1] Market Performance - The Shanghai Composite Index rose by 0.92%, the Shenzhen Component Index increased by 1.15%, the ChiNext Index gained 0.77%, and the North Star 50 Index was up by 1.05% [1] - The total trading volume in the three markets reached 31,523 billion yuan, an increase of 3,261 billion yuan compared to the previous day, with over 3,900 stocks in the three markets showing gains [1] Sector Highlights - Leading sectors included AI applications, commercial aerospace, military equipment, controllable nuclear fusion, small metals, medical services, oil and gas exploration and services, computing power leasing, and retail, all showing significant gains [1] - The AI application sector saw a surge, with stocks like Tianlong Group, Yidian Tianxia, and Guangdong Media hitting the daily limit [1] - The small metals sector continued to rise, with companies such as Zhongtung High-tech and Yunnan Zhenye reaching new highs, and Jintong Co. hitting the daily limit [1] - The commercial aerospace sector maintained its strong performance, with stocks like Galaxy Electronics and China First Heavy Industries achieving consecutive gains [1] Underperforming Sectors - The photovoltaic sector showed weakness, with Hongyuan Green Energy hitting the daily limit down, followed by declines in Daqo New Energy and Tongwei Co. [1] - The brain-computer interface sector experienced fluctuations, with companies like Meihao Medical and Aipeng Medical seeing significant declines [1]

Group 1 - The core focus of the news is the surge in stock prices of companies involved in brain-computer interface (BCI) technology, reminiscent of the AI boom following AlphaGo's victory over Lee Sedol in 2016, with a notable increase in the sector's stock prices exceeding 12% on the first trading day of 2026 [1] - Companies like Sanbo Neuroscience and Xiangyu Medical have experienced consecutive trading halts, with Xiangyu Medical and Weisi Medical achieving two 20% trading halts in four trading days, indicating strong market interest [1] - The market's enthusiasm is driven by the perceived potential of the BCI sector, with Morgan Stanley predicting that the U.S. market for BCI implant devices could reach $80 billion by 2035 [1] Group 2 - Despite the excitement, experts caution that medical-grade applications of BCI are expected to take 3 to 5 years for approval, while consumer-grade products face challenges such as bulkiness, low user engagement, and high costs [2] - Historical precedents raise concerns about the sustainability of the current hype, with past instances like the metaverse index and AI stocks experiencing significant volatility [2] - Investment in the BCI sector has seen 16 financing events totaling 983 million yuan in 2025, but no products have been commercially launched yet, indicating that many startups are still in the concept validation stage [2] Group 3 - Sanbo Neuroscience clarified that it does not engage in the research, production, or sales of BCI products, and the revenue from neuro-regulation technology is minimal, having little impact on overall performance [3] - Xiangyu Medical acknowledged its investment in BCI technology but noted that related products have not achieved significant sales volume as of the end of 2025 [3] - Some companies, like Yahui Long, faced regulatory warnings for inaccurate disclosures related to BCI partnerships, highlighting the risks of speculative trading in this sector [3]

Group 1 - The stock of Sanbo Brain Science increased by 5.39% with a turnover rate of 36.91%, and a total transaction amount of 5.687 billion yuan, showing a fluctuation of 15.81% [2] - Institutional investors net sold 93.6649 million yuan, while the Shenzhen Stock Connect recorded a net purchase of 10.4 million yuan [2] - The top five trading departments accounted for a total transaction of 1.521 billion yuan, with a net sell of 71.0119 million yuan [2] Group 2 - The latest margin trading data shows a total margin balance of 817 million yuan, with a financing balance of 813 million yuan and a securities lending balance of 4.3345 million yuan [3] - Over the past five days, the financing balance increased by 228 million yuan, representing a growth of 39.00%, while the securities lending balance rose by 2.6499 million yuan, a growth of 157.30% [3] - Specific trading data on January 8 indicates that the top buying and selling departments included the Shenzhen Stock Connect and several institutional specialized seats, with significant buy and sell amounts recorded [4]

Group 1 - The core viewpoint of the article highlights a significant surge in A-share market stocks related to brain-computer interface (BCI) technology, driven by recent developments in the sector [1] - Aipeng Medical reached a 20% daily limit increase, while Kefu Medical rose over 15%, indicating strong investor interest in BCI-related companies [1] - Notable stocks such as Nanjing Panda, Pulite, and Innovation Medical achieved a 10% daily limit increase, reflecting a broader trend of positive market sentiment towards BCI stocks [1] Group 2 - The article mentions that on January 6, Strong Brain Technology, a leading company in the BCI field, announced the completion of approximately 2 billion RMB in financing, marking a significant milestone for the industry [1] - This financing round is noted to be the second largest globally in the BCI sector, only behind Neuralink, which is owned by Elon Musk [1] - The financing success of Strong Brain Technology is expected to further stimulate interest and investment in the BCI market, potentially leading to more advancements and innovations in the field [1]

Market Overview - The three major A-share indices experienced a slight increase on January 7, with total trading volume in the Shanghai and Shenzhen markets reaching 2.88 trillion yuan, an increase of over 49 billion yuan compared to the previous day [1] - More than 2,100 stocks closed higher, with notable gains in sectors such as storage chips, state-owned capital holdings, and advanced packaging [1] Historical Highs - A total of 99 stocks reached their historical closing highs, excluding newly listed stocks from the past year. The electronics, machinery equipment, and non-ferrous metals sectors had the highest concentration of stocks hitting new highs, with 27, 13, and 11 stocks respectively [1] - The average increase for stocks that reached historical highs was 7.25%, with stocks like Shaoyang Hydraulic, Meihua Medical, and Nanda Optoelectronics hitting the daily limit [1] Top Gainers - The top gainers among stocks that reached historical highs included: - Shaoyang Hydraulic (41.33 yuan, +20.01%) - Meihua Medical (41.56 yuan, +20.01%) - Andar Intelligent (170.08 yuan, +20.00%) - Nanda Optoelectronics (55.19 yuan, +20.00%) [2] Institutional Activity - In the market, 17 stocks were net bought by institutions, with five stocks seeing net purchases exceeding 1 billion yuan. Notably, Sanbo Brain Science and Shunhao Co. received over 2 billion yuan in net purchases [2] - Conversely, Jin Feng Technology faced the highest net sell-off by institutions, amounting to over 400 million yuan, followed by Meihua Medical and Chip Source Micro with net sells of 371 million yuan and 241 million yuan respectively [3] Northbound Capital Flow - Northbound funds saw net purchases in 14 stocks, with Nanda Optoelectronics, Sanbo Brain Science, and Lei Ke Defense leading with amounts exceeding 1 billion yuan [4] - On the sell side, Jin Feng Technology topped the list with a net sell amount of 92.58 million yuan, followed by Yunhan Chip City and Shunhao Co. with net sells exceeding 40 million yuan [5] Company Announcements - Zhongke Lanyun (688332) projected a net profit increase of 366.51% to 376.51% for 2025, driven by significant growth in the fair value of investments in Moer Thread and Muxi Co. [7] - Su Meida plans to acquire a 16.92% stake in Blue Science High-Tech to achieve control [7] - Baomo Co. is planning a change in control by its actual controller [7] - Puli Te's LCP film products are suitable for use as flexible electrode materials in brain-computer interfaces [7] - Chuanjin Nuo expects a net profit increase of 144.24% to 172.64% for 2025 [7]